March 16, 2017
A New Jersey federal judge on Wednesday declined to toss claims in a patent infringement lawsuit over the blood thinner Angiomax, ruling that it wasn't clear if the plaintiff's exclusive rights over the drug's license survived the termination of the parties' contracts.